Sales rise 26.21% to Rs 735.65 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 235.31% to Rs 88.59 crore in the quarter ended June 2018 as against Rs 26.42 crore during the previous quarter ended June 2017. Sales rose 26.21% to Rs 735.65 crore in the quarter ended June 2018 as against Rs 582.90 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales735.65582.90 26 OPM %19.083.38 -PBDT157.9533.34 374 PBT146.5925.82 468 NP88.5926.42 235Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content